Quantcast

Latest Prostate Stories

2014-02-06 08:28:18

TORONTO, Feb. 6, 2014 /CNW/ - Men with metastatic castration-resistant prostate cancer (mCRPC) in Québec now have access to a therapy that can be used prior to chemotherapy. Effective February 3, 2014, the province has added ZYTIGA(®) (abiraterone acetate) to the public drug formulary for the treatment of mCRPC in men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy (ADT).(1) "ZYTIGA(® )provides men and health care professionals with a...

2014-02-03 23:20:56

Nomedexamlifeinsurance.com (http://nomedexamlifeinsurance.com) announces a new blog, “No Medical Exam Life Insurance For Prostate Cancer Patients.” (PRWEB) February 03, 2014 Nomedexamlifeinsurance.com has released a blog explaining the importance of having life insurance for prostate cancer patients! Prostate cancer patients will have difficulties finding an affordable life insurance plan. They will need to survey many policies and to compare numerous quotes before they can find...

2014-02-03 08:27:25

SAN DIEGO, Feb. 3, 2014 /PRNewswire/ -- GenomeDx Biosciences today announced that it has entered into a contractual agreement to provide its Decipher(®) prostate cancer test to FEDMED Payors. FEDMED is a national provider network that covers over 40 million lives. The Decipher( )prostate cancer classifier directly measures a patient's biological risk of developing metastatic prostate cancer. GenomeDx, which discovered and developed the Decipher test, will provide laboratory services...

2014-01-30 23:02:32

Mount Sinai experts share tips for prostate cancer prevention and new advancements in treatment and detection. New York, NY (PRWEB) January 30, 2014 Prostate cancer is the second leading cause of cancer death in American men. One in six men will be diagnosed with prostate cancer and 230,000 new cases are diagnosed annually. Overall, the five-year survival rate is 100 percent for men with the disease confined to the prostate or nearby tissue. Expert Available for Interview: Ash Tewari,...

2014-01-30 08:31:31

Multiple Studies of Decipher Prostate Cancer Classifier Presented at 2014 ASCO Genitourinary Symposium SAN DIEGO, Jan. 30, 2014 /PRNewswire/ -- GenomeDx Biosciences today announced new data demonstrating that its Decipher® Prostate Cancer Classifier, a genomic test capable of predicting the probability of developing metastatic prostate cancer, outperformed existing clinical risk factors for predicting biochemical failure and distant metastasis following radiation therapy. In addition,...

2014-01-29 12:27:03

NICE Interventional Procedure Guidance recommends use of prostatic urethral lift implants under "normal arrangements", the least restrictive classification PLEASANTON, Calif., Jan. 29, 2014 /PRNewswire/ -- NeoTract, Inc., today announced that the UK's National Institute for Health and Clinical Excellence (NICE) has issued an Interventional Procedure Guidance (IPG) approving the UroLift prostatic urethral lift implant for use by UK doctors. The NICE guidance was made following...

2014-01-24 13:33:49

No meaningful decline in emotional quality of life 2 years after therapy, reports the Journal of Urology A new study published in the Journal of Urology® reports that prostate cancer patients treated with androgen deprivation therapy (ADT) experienced changes in mental and emotional well-being during treatment, although there was no meaningful decline in emotional quality of life two years after treatment. Investigators at the University of California-San Francisco recommend counseling...

2014-01-20 10:32:20

Men who walked at a fast pace prior to a prostate cancer diagnosis had more regularly shaped blood vessels in their prostate tumors compared with men who walked slowly, providing a potential explanation for why exercise is linked to improved outcomes for men with prostate cancer, according to results presented here at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research, held Jan. 18-21. Men who engage in higher levels of physical activity have been...

Melatonin May Play A Role In Reducing Risk Of Prostate Cancer
2014-01-20 03:56:23

American Association for Cancer Research Higher levels of melatonin, a hormone involved in the sleep-wake cycle, may suggest decreased risk for developing advanced prostate cancer, according to results presented in San Diego at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research, held Jan. 18-21. Melatonin is a hormone that is produced exclusively at night in the dark and is an important output of the circadian rhythm, or the body's inherent 24-hour...

2014-01-10 08:23:58

Nomogram aims to enable informed decision-making and personalized treatment SEATTLE, Jan. 10, 2014 /PRNewswire/ -- Studies have found that prostate cancer is overdiagnosed in up to 42 percent of cases, prompting men to receive unnecessary treatment that can cause devastating side effects, including impotence and incontinence. Now, researchers at Fred Hutchinson Cancer Research Center and the University of Washington have developed a personalized tool that can predict the likelihood...


Latest Prostate Reference Libraries

Prostate
2013-03-04 15:21:55

The male prostate gland acts as an exocrine gland in the male reproductive system. It is a firm, partly muscular, chestnut sized gland near the neck of the urethra in males. Formation and Orientation The prostate is usually formed within the ninth week of the embryonic stage in reproductive development. The prostate can be separated into either “lobes” or “zones”. When looking at a prostate divided into zones, there are four distinct regions. The first zone is the Peripheral...

More Articles (1 articles) »
Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related